Imidlertid antyder begrænsede publicerede data, at sikkerhedsprofilen hos unge fra 12 til 16 år, der modtager AVONEX 30 mikrogram i. m. én gang om ugen, ligner den, der ses hos voksne.
However, limited published data suggest that the safety profile in adolescents from 12 to 16 years of age receiving AVONEX 30 micrograms IM once per week is similar to that seen in adults.